[BIOCYTIN13]DYNORPHIN-A 1-13 AMIDE - A POTENTIAL PROBE FOR THE KAPPA-OPIOID RECEPTOR

被引：3
|
作者：
HOCHHAUS, G
PATTHY, A
SCHWIETERT, R
SANTI, DV
SADEE, W
机构：
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT SCI,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,CTR BIOMOLEC RESOURCE,SAN FRANCISCO,CA 94143
来源：
PHARMACEUTICAL RESEARCH | 1988年 / 5卷 / 12期
关键词：
D O I：
10.1023/A:1015944903360
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：790 / 794
页数：5
相关论文
共 50 条
  • [31] INTRINSIC ACTIVITY AND EFFECTS OF GUANYL-5'-YL IMIDODIPHOSPHATE, GPP(NH)P AND SODIUM-ION ON THE AFFINITY OF DYNORPHIN 1-13, NALORPHINE AND NALORPHINE-7,8-OXIDE TO KAPPA-OPIOID RECEPTOR
    TAKAYANAGI, I
    OKUMURA, K
    KONNO, F
    KOIKE, K
    CHO, N
    HIROBE, M
    GENERAL PHARMACOLOGY, 1985, 16 (06): : 617 - 619
  • [32] NEUROLOGICAL DYSFUNCTION AFTER INTRATHECAL INJECTION OF DYNORPHIN-A (1-13) IN THE RAT .1. INJECTION PROCEDURES MODIFY PHARMACOLOGICAL RESPONSES
    LONG, JB
    MOBLEY, WC
    HOLADAY, JW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 246 (03): : 1158 - 1166
  • [33] SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ANALOGS OF DYNORPHIN-A(1-13) SUBSTITUTED IN POSITION-2 AND POSITION-4 - DESIGN OF [ALA2,TRP4]-DYN-A(1-13) AS A PUTATIVE SELECTIVE OPIOID ANTAGONIST
    LEMAIRE, S
    TURCOTTE, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1986, 64 (06) : 673 - 678
  • [34] BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF THE NEW OPIOID PEPTIDE DYNORPHIN-(1-13) - COMPARISON WITH OTHER NEUROPEPTIDES
    ZWIERS, H
    ALOYO, VJ
    GISPEN, WH
    LIFE SCIENCES, 1981, 28 (22) : 2545 - 2551
  • [35] Dynorphin A(1-13) analgesia in opioid-treated patients with chronic pain - A controlled pilot study
    Portenoy, RK
    Caraceni, A
    Cherny, NI
    Goldblum, R
    Ingham, J
    Inturrisi, CE
    Johnson, JH
    Lapin, J
    Tiseo, PJ
    Kreek, MJ
    CLINICAL DRUG INVESTIGATION, 1999, 17 (01) : 33 - 42
  • [36] DYNORPHIN(1-13), A LONG-LASTING INHIBITOR OF OPIATE RECEPTOR-BINDING INVITRO
    GARZON, J
    JEN, MF
    SANCHEZBLAZQUEZ, P
    LEE, NM
    LIFE SCIENCES, 1982, 31 (16-1) : 1789 - 1792
  • [37] Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid receptor agonist
    Hiramatsu, M
    Murasawa, H
    Mori, H
    Kameyama, T
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (05) : 920 - 926
  • [38] SELECTIVE INVOLVEMENT OF KAPPA OPIOID AND PHENCYCLIDINE RECEPTORS IN THE ANALGESIC AND MOTOR EFFECTS OF DYNORPHIN-A-(1-13)-TYR-LEU-PHE-ASN-GLY-PRO
    SHUKLA, VK
    BANSINATH, M
    DUMONT, M
    LEMAIRE, S
    BRAIN RESEARCH, 1992, 591 (01) : 176 - 180
  • [39] ICI-174864, A PUTATIVE DELTA-OPIOID ANTAGONIST, REVERSES ENDOTOXEMIC HYPOTENSION - PRETREATMENT WITH DYNORPHIN 1-13, A KAPPA-AGONIST, BLOCKS THIS ACTION
    LONG, JB
    RUVIO, BA
    GLATT, CE
    HOLADAY, JW
    NEUROPEPTIDES, 1984, 5 (1-3) : 291 - 294
  • [40] Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the κ-opioid receptor does not affect dynorphin A(1-13) affinity and function
    Ferguson, DM
    Kramer, S
    Metzger, TG
    Law, PY
    Portoghese, PS
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) : 1251 - 1252
12345